Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bio-Techne Corp TECH

Healthcare  —  Biotechnology
72.61 0.04 0.06% as of 25 Sep
Market cap
$11.4B
P/E
62.1×
S&P 500 Member Dividend Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Bio-Techne Corp (TECH) Price to free cash flow

As of 25 September 2026, Bio-Techne Corp (TECH) trades at a price to free cash flow of 43.0×. Over the past ten years it has ranged from 16.9× (January 2016) to 79.3× (February 2021); the current reading is higher than 47% of that period. That is above the Biotechnology industry median of 21.2× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2026 41.9× 32.51%
FY2025 31.6× (33.96%)
FY2024 47.8× (19.42%)
FY2023 59.4× 22.42%
FY2022 48.5× (14.44%)
FY2021 56.7× (13.79%)
FY2020 65.7× 29.86%
FY2019 50.6× 36.15%
FY2018 37.2× 8.98%
FY2017 34.1× 3.51%

Quarterly

Period Price to free cash flow Change
Jun 2026 41.9× 38.14%
Mar 2026 30.3× (26.26%)
Dec 2025 41.1× 6.46%
Sep 2025 38.6× 22.19%
42 more quarters

Against its own ten years

Low 16.9× High 79.3×
Ten-year median 44.4×
Current reading's percentile 47

Price to free cash flow against peers

Company Price to free cash flow
BBIO BridgeBio Pharma, Inc. compare n/m
MDGL Madrigal Pharmaceuticals, Inc. compare n/m
SMMT Summit Therapeutics PLC compare n/m
AXSM Axsome Therapeutics, Inc. compare n/m
BMRN BioMarin Pharmaceutical Inc. compare 16.1×
HALO Halozyme Therapeutics, Inc. compare 16.6×
KRYS Krystal Biotech, Inc. compare 39.7×
TECH Bio-Techne Corp 43.0×
CORT Corcept Therapeutics Incorporated compare 114×
Biotechnology industry median 21.2×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on TECH